Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The group sequential triangular test for phase II cancer clinical trials

E Bellissant1, J Bénichou, C Chastang

  • 1Centre Hospitalier Regional, Paris, France.

American Journal of Clinical Oncology
|August 1, 1996
PubMed
Summary

The Triangular Test offers an efficient method for phase II cancer trials, allowing early stopping for clear efficacy or inefficacy. This approach reduces sample size while maintaining statistical accuracy for chemotherapy evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): About three case reports.

Gynecologic oncology reports·2025
Same author

Comparative analysis of quality scores images between second- and third-trimester ultrasound scan.

Journal of gynecology obstetrics and human reproduction·2024
Same author

Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.

Thrombosis research·2024
Same author

Post-traumatic stress disorder in hospital doctors after the COVID-19 pandemic.

Occupational medicine (Oxford, England)·2024
Same author

[Virological diagnosis of anterior herpetic ocular disease on tear sample: A simple and non-invasive technique].

Journal francais d'ophtalmologie·2022
Same author

[Retinal involvement in hypocomplementemic urticarial vasculitis (McDuffie syndrome): Report of two cases].

Journal francais d'ophtalmologie·2021

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Biostatistics

Background:

  • Phase II cancer clinical trials are typically noncomparative, focusing on preliminary efficacy assessment.
  • Ethical considerations necessitate early trial termination upon clear demonstration of inefficacy or efficacy.
  • Existing methods may not optimally balance early stopping with statistical rigor in phase II settings.

Purpose of the Study:

  • To present the Triangular Test for practical application in phase II oncology trials.
  • To facilitate the design and analysis of phase II cancer studies using this group sequential method.
  • To highlight the advantages of the Triangular Test over alternative methods for early-phase cancer trials.

Main Methods:

  • Extension of the Triangular Test, a group sequential method, from phase III to phase II clinical trials.

Related Experiment Videos

  • Demonstration of the method's performance regarding type I error rate and power.
  • Discussion of practical aspects for implementing the Triangular Test in oncology trial design and analysis.

    • Main Results:

    • The Triangular Test maintains type I error rate and power close to nominal values.
    • This method demonstrates a reduction in sample size compared to other approaches.
    • Early termination for clear efficacy or inefficacy is effectively managed.

    Conclusions:

    • The Triangular Test provides a statistically sound and efficient approach for phase II cancer trials.
    • Its practical application can enhance decision-making and resource allocation in oncology drug development.
    • This method supports ethical trial conduct by allowing timely cessation of ineffective treatments.